Clinical Trials Browser

Phase EARLY_PHASE1 × Has results × Waldenstrom Macroglobulinemia × Clear all

NCT03771157 2024-03-15

Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors

Phase EARLY_PHASE1 Completed

33 enrolled 11 charts

LymphoidOther hematologic neoplasm

Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell